To further demonstrate that promoter hypermethylation contributes to the lack of expression of RASSF1A in the NPC cell lines, we assessed the effect of 5-aza-2'-deoxycytidine, a drug that inhibits DNA methylation. Here, RASSF1 is linked to nasopharyngeal carcinoma.